Literature DB >> 33569847

Diverse Synthesis of Chiral Trifluoromethylated Alkanes via Nickel-Catalyzed Asymmetric Reductive Cross-Coupling Fluoroalkylation.

Yue Min1, Jie Sheng2, Jian-Liang Yu2, Shan-Xiu Ni2, Guobin Ma1, Hegui Gong1, Xi-Sheng Wang2.   

Abstract

The trifluoromethyl group represents one of the most functional and widely used fluoroalkyl groups in drug design and screening, while the drug candidates containing chiral trifluoromethyl-bearing carbons are still few due to the lack of efficient methods for the asymmetric introduction of trifluoromethyl group into organic molecules. Herein, we described a nickel-catalyzed asymmetric trifluoroalkylation of aryl iodides, for the first time, by utilizing reductive cross-coupling in enantioselective fluoroalkylation. This novel method has demonstrated high efficiency, mild conditions, and excellent functional group tolerance, especially for substrates containing diverse pharmaceutical and bioactive molecules moieties. This strategy provided an efficient and facile way for diversity-oriented synthesis of chiral trifluoromethylated alkanes.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  asymmetric trifluorofluoroalkylation; late-stage fluoroalkylation; nickel; reductive cross-coupling

Year:  2021        PMID: 33569847     DOI: 10.1002/anie.202101076

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  2 in total

1.  Nickel-catalyzed cross-electrophile allylation of vinyl bromides and the modification of anti-tumour natural medicine β-elemene.

Authors:  Yang Ye; Xiang Qi; Bing Xu; Ying Lin; Huan Xiang; Liang Zou; Xiang-Yang Ye; Tian Xie
Journal:  Chem Sci       Date:  2022-05-12       Impact factor: 9.969

2.  Synthesis of α,γ-Chiral Trifluoromethylated Amines through the Stereospecific Isomerization of α-Chiral Allylic Amines.

Authors:  Víctor García-Vázquez; Pablo Martínez-Pardo; Alexandru Postole; A Ken Inge; Belén Martín-Matute
Journal:  Org Lett       Date:  2022-05-19       Impact factor: 6.072

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.